Using Space Medicinal Chemistry Against SARS-CoV-2: 
SpaceMedChem Consortium–Project 1.

Authors

  • Gergő Mezőhegyi Innostudio Inc., Záhony u. 7., H-1034 Budapest, Hungary
  • Balázs Buchholcz Innostudio Inc., Záhony u. 7., H-1034 Budapest, Hungary
  • István Puskás CycloLab Cyclodextrin R&D Laboratory Ltd., Illatos út 7, H-1097 Budapest, Hungary
  • Lajos Szente CycloLab Cyclodextrin R&D Laboratory Ltd., Illatos út 7, H-1097 Budapest, Hungary
  • Tamás Sohajda CycloLab Cyclodextrin R&D Laboratory Ltd., Illatos út 7, H-1097 Budapest, Hungary
  • Ferenc Darvas Innostudio Inc., Záhony u. 7., H-1034 Budapest, Hungary

DOI:

https://doi.org/10.33892/aph.2021.91.272-273

Keywords:

SARS-CoV-2 SpaceMedChem, Remdesivir, cyclodextrin, stability

Published

2021-11-15

How to Cite

(1)
Mezőhegyi, G.; Buchholcz, B.; Puskás, I.; Szente, L.; Sohajda, T.; Darvas, F. Using Space Medicinal Chemistry Against SARS-CoV-2: 
SpaceMedChem Consortium–Project 1. Acta Pharm Hung 2021, 91, 272-273.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License